₹135
▼ -1.9 -1.39%
17 Jul 2026
NSE Listed · Pharmaceuticals
Bio Medica Laboratories Limited (BMLL)
Volume: 0Avg Vol 1W: 1,18,800Avg Vol 1M: 1,34,95552W Range:₹101.5₹148
Key Ratios
Checked just nowMarket Cap—
Current Price₹135
Previous Close₹136.9
High / Low (52w)₹148 / ₹101.5
Volume0
Avg Vol (1W)1,18,800
Avg Vol (1M)1,34,955
Stock P/E0
Book Value₹49.24
Dividend Yield0%
ROE66.48%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹0
P/B2.74
Debt / Equity1.3
50 DMA—
200 DMA—
Day change-1.39%
Price Chart
₹135▲ 16.58% · 1Y
2026-05-292026-07-16
20-day avg volume: 1.5L shares
Pros
- Healthy return on equity of 66.5%.
- Company is almost debt-free.
- Revenue grew 150% YoY.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue | ₹16 Cr | ₹15 Cr | ₹38 Cr |
| EBITDA | ₹1 Cr | ₹5 Cr | ₹14 Cr |
| Net Profit | ₹0 Cr | ₹2 Cr | ₹10 Cr |
| EPS | 0.36 | 2.72 | 10.67 |
Balance Sheet
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Total Assets | ₹18 Cr | ₹20 Cr | ₹39 Cr |
| Total Liabilities | ₹15 Cr | ₹15 Cr | ₹24 Cr |
| Equity | ₹2 Cr | ₹5 Cr | ₹15 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating | ₹3 Cr | ₹2 Cr | ₹-2 Cr |
| Investing | ₹-2 Cr | ₹-2 Cr | ₹0 Cr |
| Financing | ₹-2 Cr | ₹0 Cr | ₹3 Cr |
| Free Cash Flow | ₹3 Cr | ₹2 Cr | ₹-2 Cr |
Shareholding
Promoter 67.7% Institutions 2.59% Public 29.71%
Efficiency & Working Capital
ROCE62.9%
Interest Coverage10.7
Dividend Payout—
Debtor Days39 d
Inventory Days173 d
Payable Days41 d
Cash Conversion Cycle172 d
Working Capital Days213 d
Shareholding Details
As of 2026-05-31
Promoter67.7%
FII0.3%
DII2.3%
Institutions2.6%
Public29.7%
Promoter Pledge0%
No. of Shareholders1,195
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Aug 2025 | Aug 2025 | May 2026 | May 2026 |
|---|---|---|---|---|
| Promoters | 100% | 100% | 67.7% | 67.7% |
| FIIs | 0% | 0% | 0.3% | 0.3% |
| DIIs | 0% | 0% | 2.3% | 2.3% |
| Public | 0% | 0% | 29.7% | 29.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 7 | 7 | 1,195 | 1,195 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Mukesh Mehta | Shareholding of Promoter and Promoter Group | 33.9% | 42,56,316 |
| Pradeep Mehta | Shareholding of Promoter and Promoter Group | 33.9% | 42,56,225 |
| Garima Mehta | Shareholding of Promoter and Promoter Group | 0% | 92 |
| Anju Mehta | Shareholding of Promoter and Promoter Group | 0% | 92 |
| Tara Mehta | Shareholding of Promoter and Promoter Group | 0% | 92 |
| Lokesh Jain | Shareholding of Promoter and Promoter Group | 0% | 92 |
| Arvind Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Greyana Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Siana Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dharvi Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tanishi Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Lalit Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Babulal Hagamilal Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pista Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jain Naginbhen Babulal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Gourav Kumar Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Manish Babulal Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pankaj Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vimalkumar Babulal Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Lincia Healthcare Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sears Phytochem Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vitamax Healthcare Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bio Medica Parenterals | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tiger Strategies Fund -i | Public Shareholding | 0% | 2,90,000 |
| Yashwant Amratlal Thakkar | Public Shareholding | 0% | 2,16,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Mukesh Mehta | 0 | 0% | 2026-05-28 |
| Pradeep Mehta | 0 | 0% | 2026-05-28 |
| Garima Mehta | 0 | 0% | 2026-05-28 |
| Anju Mehta | 0 | 0% | 2026-05-28 |
| Tara Mehta | 0 | 0% | 2026-05-28 |
| Lokesh Jain | 0 | 0% | 2026-05-28 |
| Arvind Mehta | 0 | 0% | 2026-05-28 |
| Greyana Mehta | 0 | 0% | 2026-05-28 |
| Siana Mehta | 0 | 0% | 2026-05-28 |
| Dharvi Mehta | 0 | 0% | 2026-05-28 |
| Tanishi Mehta | 0 | 0% | 2026-05-28 |
| Lalit Jain | 0 | 0% | 2026-05-28 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Pradeep Mehta | ED / MD / Promoter | 2025 |
| Mukesh Mehta | WTD & Executive Director | 2025 |
| Surabhi Mahajan | Non Executive Director | 2025 |
| Divya Khandelwal | Independent Non Exe. Director | 2025 |
| Sumeet Bansal | Independent Non Exe. Director | 2025 |
| Rahul Kumar | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 16 | 9 | 9 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 4 | 0 | 4 |
| 2025 | 0 | 0 | 0 | 3 | 0 | 3 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Company Information
Incorporated2015
Investor Email[email protected]
📍 Plot No.11B-11C Sector-E, Sanwer Rd Industrial Area, Indore, Madhya Pradesh, 452015
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
IPO History
| IPO | listed · listed 2026-05-29 |
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search